Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,543 | -135,747 | -97,885 | -61,577 | -25,798 |
| Depreciation Amortization | 326 | 790 | 571 | 365 | 176 |
| Accounts receivable | 33,823 | -33,823 | 0 | 0 | N/A |
| Other Working Capital | 29,260 | 186,732 | 55,143 | 49,218 | 41,805 |
| Other Operating Activity | -28,394 | 39,954 | 4,407 | 2,473 | 1,251 |
| Operating Cash Flow | $-9,528 | $57,906 | $-37,764 | $-9,521 | $17,434 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 125,151 | 64,874 | 15,314 |
| PPE Investments | -427 | -2,662 | -2,614 | -1,358 | -109 |
| Purchase Of Investment | -116,366 | -147,009 | -132,138 | -118,684 | -100,160 |
| Sale Of Investment | 24,490 | 162,376 | N/A | N/A | N/A |
| Investing Cash Flow | $-92,303 | $12,705 | $-9,601 | $-55,168 | $-84,955 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -20 | -19 | -6 | -3 |
| Common Stock Issued | 1,748 | 66,966 | 63,436 | 61,094 | 61,185 |
| Financing Cash Flow | $1,746 | $66,946 | $63,417 | $61,088 | $61,182 |
| Beginning Cash Position | 188,616 | 51,059 | 49,778 | 49,778 | 49,778 |
| End Cash Position | 88,531 | 188,616 | 65,830 | 46,177 | 43,439 |
| Net Cash Flow | $-100,085 | $137,557 | $16,052 | $-3,601 | $-6,339 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,528 | 57,906 | -37,764 | -9,521 | 17,434 |
| Capital Expenditure | -427 | -2,662 | -2,614 | -1,358 | -109 |
| Free Cash Flow | -9,955 | 55,244 | -40,378 | -10,879 | 17,325 |